Numerical aberrations of chromosome I in cervical intraepithelial neoplasia are strongly associated with infection with high-risk human papillomavirus types

Journal of Pathology

Volumn 198, Issue 3, 2002, Pages 300-309

  Bulten, Johan ^a   Melchers, Willem J G ^a   Kooy Smits, Maria M ^a   De Wilde, Peter C M ^a   Poddighe, Pino J ^b   Robben, Johanna C M ^a   Macville, Merryn V E ^a   Massuger, Leon F A G ^a   Bakkers, Judith M J E ^a   Hanselaar, Antonius G J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CIH; HPV; ISH; Numerical chromosome aberrations

Indexed keywords

ARTICLE; CARCINOMA; CENTROMERE; CHROMOSOME 1; CHROMOSOME ABERRATION; CHROMOSOME NUMBER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISOMY; DNA PROBE; EPITHELIUM DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SAMPLE; STATISTICAL ANALYSIS; TETRASOMY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; HUMANS; IN SITU HYBRIDIZATION; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0036841908     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1222     Document Type: Article

References (48)

1. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 and 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 272-278.
2. Schiffman MH, Bauer H, Hoover R, et al. Epidemiologic evidence showing that HPV infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-964.
3. Walboomers JMM, De Roda Husman AM, Van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections: critical review of methods and prevalence studies in relation to cervical cancer. In Human Papillomavirus and Cervical Cancer. Biology and Immunology, Stern PL, Stanley MA (eds). Oxford University Press: Oxford, 1994; 41-71.
4. Herrington CS. Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology. J Clin Pathol 1994; 47: 1066-1072.
5. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Pathol 1999; 189: 12-19.
6. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995; 69: 3074-3083.
7. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345: 1533-1536.
8. Remmink AJ, Walboomers JMM, Helmerhorst TJM, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306-311.
9. Cuzick J, Terry G, Ho L, Hollingsworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994; 69: 167-171.
10. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with cytological diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946-954.
11. Bollen LJ, Tjong-A-Hung SP, van der Velden J, et al. Human papillomavirus deoxyribonucleic acid detection in mildly or moderately dysplastic smears: a possible method for selecting patients for colposcopy. Am J Obstet Gynecol 1997; 177: 548-553.
12. Melchers WJG, Bakkers JMJE, Wang J, et al. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Am J Pathol 1999; 155: 1473-1478.
13. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20-25.
14. Bibbo M, Dytch HE, Alenghat E, Bartels PH, Wied GL. DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol 1989; 92: 261-265.
15. Hanselaar AG, Vooijs GP, Mayall BH, Pahlplatz MMM. Van't Hof-Grootenboer AE. DNA changes in progressive cervical intraepithelial neoplasia. Anal Cell Pathol 1992; 4: 315-324.
16. Segers P, Haesen S, Amy JJ, De Sutter Ph, Van Dam P, Kirsch-Volders M. Detection of premalignant stages in cervical smears with a biotinylated probe for chromosome 1. Cancer Genet Cytogenet 1994; 75: 120-129.
17. Steinbeck RG. Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis. Acta Oncol 1996; 36: 3-12.
18. Southern SA, Evans MF, Herrington CS. Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses. Cancer Res 1997; 57: 4210-4213.
19. Bulten J, Poddighe PJ, Robben JCM, Gemmink JH, De Wilde PCM, Hanselaar AGJM. Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol 1998; 152: 495-503.
20. Graham DA, Southern SA, McDicken IW, Herrington S. Interphase cytogenetic evidence for distinct genetic pathways in the development of squamous neoplasia of the uterine cervix. Lab Invest 1998; 78: 289-296.
21. Poddighe PJ, Bulten J, Kerstens HMJ, Robben JCM, Melchers WJG, Hanselaar AGJM. Human papilloma virus detection by in situ hybridisation signal amplification based on biotinylated tyramine deposition. J Clin Pathol Mol Pathol 1996; 49: M340-M344.
22. Speel EJM, Hopman AHN, Komminoth P. Amplification methods to increase the sensitivity of in situ hybridization: play card(s). J Histochem Cytochem 1999; 47: 281-288.
23. Anderson MC. Cervical precancer. In Female Reproductive System in Systemic Pathology, Anderson MC (ed). Churchill Livingstone: Edinburgh, 1991; 92-96.
24. Gompel C, Silverberg SG. The cervix. In Pathology in Gynecology and Obstetrics, Gompel C, Silverberg SG (eds). JB Lippincott: Philadelphia, 1994; 109-115.
25. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In Blaustein's Pathology of the Female Genital Tract, Kurman RJ (ed). Springer-Verlag: New York, 1994; 244-253.
26. Cooke HJ, Hindley J. Cloning of human satellite III DNA. Different components are on different chromosomes. Nucleic Acids Res 1979; 6: 3177-3197.
27. Kerstens HMJ, Poddighe PJ, Hanselaar AGJM. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 1995; 43: 347-352.
28. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517.
29. Melchers WJG, Bakkers JMJE, Wang J, et al. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 1999; 155: 1473-1478.
30. Southern S, Herrington CS. The assessment of intra-tumoral karyotypic heterogeneity by interphase cytogenetics in paraffin wax sections. J Clin Pathol Mol Pathol 1996; 49: M283-M289.
31. Rihet S, Lorenzato M, Clavel C. Oncogenic human papillomaviruses and ploidy in cervical lesions. J Clin Pathol 1996; 49: 892-896.
32. Monsonego J, Valensi P, Zerat L, Clavel C, Birembaut P. Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1997; 104: 723-727.
33. Davey DD, Zaleski S, Sattich M, Gallion H. Prognostic significance of DNA cytometry of postirradiation cervicovaginal smears. Cancer 1998; 84: 11-16.
34. Aoyama C, Peters J, Senadheera S, Liu P, Shimada H. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction. Diagn Mol Pathol 1998; 7: 324-330.
35. Barbosa MS, Edmonds C, Fisher C, Schiller JT. In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J Virol 1991; 65: 292-298.
36. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
37. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus type 16 or 18. EMBO J 1991; 10: 4129-4135.
38. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livinston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993; 73: 487-497.
39. Munger K. The molecular biology of cervical cancer. J Cell Biochem Suppl 1995; 23: 55-60.
40. Heselmeyer K, Schrock E, du Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 1996; 93: 479-484.
41. Heselmeyer K, Macville M, Schrock E, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 1997; 19: 233-240.
42. Kirchhoff M, Rose H, Petersen BL, et al. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 1999; 24: 144-150.
43. Giannoudis A, Evans MF, Southern SA, Herrington CS. Basal keratinocyte tetrasomy in low-grade intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific. Br J Cancer 2000; 82: 424-428.
44. Southern SA, Noya F, Meyers C, Broker TR, Chow LT, Herrington S. Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. Cancer Res 2001; 61: 4858-4863.
45. Tabrizi SN, Fairly CK, Chen S, et al. Epidemiological characteristics of women with high-grade CIN who do and do not have human papillomavirus. Br J Obstet Gynaecol 1999; 106: 252-257.
46. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357: 1831-1836.
47. Ried T. Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am J Pathol 1998; 152: 325-327.
48. Kerstens HMJ, Robben JCM, Poddighe PJ, et al. A novel cell-processing method for multiple molecular diagnostic analysis of the uterine cervix. J Histochem Cytochem 2000; 48: 709-718.